Contact
Please use this form to send email to PR contact of this press release:
Vidac Pharma Receives 'Buy' Rating and Increased Valuation from Sphene Capital, Underscoring Strong Growth Prospects
TO:
Max Herzberg
Vidac pharma Holding Plc
+972 54-425-7381